Genoscience Pharma is proud that FDA granted an Orphan Drug Designation to GNS561 (a Genoscience’s innovation) for the treatment of Cholangiocarcinoma to GENFIT
Genoscience Pharma is proud that FDA granted an Orphan Drug Designation to GNS561 (a Genoscience’s innovation) for the treatment of Cholangiocarcinoma to GENFIT